Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Market Closed 01-30 16:00:00 EST

17.50

-0.22

-1.24%

盘后17.30

-0.20-1.14%

19:56 EST

High17.78	Low17.03	Vol2.98M
Open17.68	D1 Closing17.72	Amplitude4.24%
Mkt Cap3.23B	Tradable Cap1.42B	Total Shares184.69M
T/O51.64M	T/O Rate3.66%	Tradable Shares81.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":17.5,"timestamp":1769806800000,"preClose":17.72,"halted":0,"volume":2981759,"hourTrading":{"tag":"盘后","latestPrice":17.3,"preClose":17.5,"latestTime":"19:56 EST","volume":40795,"amount":713661.253,"timestamp":1769820965772,"change":-0.2,"changeRate":-0.011429,"amplitude":0.011429},"delay":0,"changeRate":-0.01241534988713312,"floatShares":81382003,"shares":184689564,"eps":-1.30264,"marketStatus":"Market Closed","change":-0.22,"latestTime":"01-30 16:00:00 EST","open":17.68,"high":17.782,"low":17.03,"amount":51642381.186165,"amplitude":0.042438,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.30264,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770022800000},"marketStatusCode":7,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":17.72,"preHourTrading":{"tag":"盘前","latestPrice":17.61,"preClose":17.72,"latestTime":"09:29 EST","volume":2300,"amount":40546.716100000005,"timestamp":1769783359358,"change":-0.11,"changeRate":-0.006208,"amplitude":0.012415},"postHourTrading":{"tag":"盘后","latestPrice":17.3,"preClose":17.5,"latestTime":"19:56 EST","volume":40795,"amount":713661.253,"timestamp":1769820965772,"change":-0.2,"changeRate":-0.011429,"amplitude":0.011429},"volumeRatio":1.0986926858353996,"impliedVol":0.7226,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/LEGN","defaultTab":"news","newsList":[{"id":"2606513294","title":"Legend Biotech Appoints Robin Meng to Board as Li Zhu and Yau Wai Man Philip Resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2606513294","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606513294?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:05","pubTimestamp":1769411144,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation announced the appointment of Robin Meng to its Board of Directors as a Class III director, effective January 20, 2026, replacing Dr. Li Zhu, who resigned from the Board on the same date. Yau Wai Man Philip also resigned from the Board, and Tomas Heyman was appointed as the new chair of the Audit Committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL4p9bWp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4139","LEGN","BK4588"],"gpt_icon":0},{"id":"2605406574","title":"Genscript Chairman Joins Board of Nasdaq-Listed Associate Legend Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2605406574","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605406574?lang=en_us&edition=fundamental","pubTime":"2026-01-23 22:39","pubTimestamp":1769179147,"startTime":"0","endTime":"0","summary":"Genscript Biotech ( ($HK:1548) ) has shared an update. Genscript Biotech has announced that its chairman and executive director, Jiange (Robin) Men...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genscript-chairman-joins-board-of-nasdaq-listed-associate-legend-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genscript-chairman-joins-board-of-nasdaq-listed-associate-legend-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4585","BK4505","BK4588","LEGN","LABU","BK4139"],"gpt_icon":0},{"id":"1108693804","title":"GENSCRIPT BIO (01548) Appoints Meng Jiange to Legend Biotech's Board","url":"https://stock-news.laohu8.com/highlight/detail?id=1108693804","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108693804?lang=en_us&edition=fundamental","pubTime":"2026-01-23 22:18","pubTimestamp":1769177893,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) announced that, effective January 20, 2026, the board of directors of Legend Biotech Corporation (\"Legend,\" an associate of the company whose shares are listed on the Nasdaq...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","BK4505","BK4588","HK0000320223.HKD","LEGN","BK1583","BK4585","HK0000320264.USD","BK1576","BK4139","01548","BK1141","HK0000306685.HKD"],"gpt_icon":0},{"id":"2605566476","title":"Could New FDA MRD Guidance Quietly Redefine Legend Biotech’s (LEGN) Multiple Myeloma Ambitions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605566476","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605566476?lang=en_us&edition=fundamental","pubTime":"2026-01-23 14:52","pubTimestamp":1769151142,"startTime":"0","endTime":"0","summary":"The FDA recently issued draft guidance endorsing minimal residual disease negativity and complete response rates as accelerated approval benchmarks in multiple myeloma, a framework that directly supports Legend Biotech’s existing trial design for its CAR-T therapy CARVYKTI in earlier treatment lines.\nThis alignment between regulator expectations and Legend Biotech’s CARTITUDE program could streamline its development path and heighten the therapy’s profile in frontline myeloma care.\nWith this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/could-new-fda-mrd-guidance-quietly-redefine-legend-biotechs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/could-new-fda-mrd-guidance-quietly-redefine-legend-biotechs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LABU","BK4588","BK4139","BK4505","LEGN"],"gpt_icon":0},{"id":"2605994464","title":"TD Cowen Downgrades Legend Biotech to Hold From Buy, Adjusts Price Target to $21 From $62","url":"https://stock-news.laohu8.com/highlight/detail?id=2605994464","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605994464?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:04","pubTimestamp":1769087095,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of buy and mean price target of $65.54, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","COWN","LEGN","TD"],"gpt_icon":0},{"id":"2605495472","title":"Goldman Sachs Keeps Their Buy Rating on Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495472","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605495472?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:19","pubTimestamp":1769084343,"startTime":"0","endTime":"0","summary":"In a report released today, from Goldman Sachs maintained a Buy rating on Legend Biotech, with a price target of $56.46. In addition to Goldman Sac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-keeps-their-buy-rating-on-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-keeps-their-buy-rating-on-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LEGN"],"gpt_icon":0},{"id":"2605949367","title":"Legend Biotech Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2605949367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605949367?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:48","pubTimestamp":1769082480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2026 06:48 ET (11:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LEGN"],"gpt_icon":0},{"id":"2605498535","title":"Legend Biotech: Undervalued CARVYKTI Leader Offering a Compelling Buy Opportunity Despite Transient Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2605498535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605498535?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:16","pubTimestamp":1769080573,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor maintained a Buy rating on Legend Biotech today and set a price target of $50.00. Mitchell Kapoor has given...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/legend-biotech-undervalued-carvykti-leader-offering-a-compelling-buy-opportunity-despite-transient-setback-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/legend-biotech-undervalued-carvykti-leader-offering-a-compelling-buy-opportunity-despite-transient-setback-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LEGN","BK4139","BK4505","BK4585","BK4588"],"gpt_icon":0},{"id":"2605498586","title":"Legend Biotech price target lowered to $50 from $60 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2605498586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605498586?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:10","pubTimestamp":1769080215,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Legend Biotech (LEGN) to $50 from $60 and keeps a Buy rating on the shares. The firm says Carvyt...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-price-target-lowered-to-50-from-60-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-price-target-lowered-to-50-from-60-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LEGN"],"gpt_icon":0},{"id":"2605450781","title":"U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605450781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605450781?lang=en_us&edition=fundamental","pubTime":"2026-01-22 15:17","pubTimestamp":1769066226,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne TechnologiesJan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL4N3YN0FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0316494557.USD","CTSH","SSNC","BKU","LU0965509101.SGD","MCB","CHE","IE00BKVL7J92.USD","LEGN","SCHW","EOLS","HAL","GLDD","FOLD","BXP","LU0882574055.USD","MRK","CAH","ORN","HCA","BK4122","CNC","KRMN","NOW","LU0477156953.USD","CROX","LU0234570918.USD","OZK","MOH","GOLF","KMI","COR","CVLT","KTOS","CFG","LU2931357623.SGD","NIC","JNJ","LU1119994496.HKD","BTSG","OPCH","RAPT","DCOM","REAL","MKSI","GDRX","EGBN","ACHC"],"gpt_icon":1},{"id":"1169873332","title":"Hong Kong Stock Movement | GENSCRIPT BIO (01548) Plummets Over 7%, Affiliate Legend Biotech's Shares Tumble More Than 11% Overnight","url":"https://stock-news.laohu8.com/highlight/detail?id=1169873332","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169873332?lang=en_us&edition=fundamental","pubTime":"2026-01-22 11:04","pubTimestamp":1769051062,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) experienced a sharp decline of over 7%. At the time of writing, the stock was down 6.98%, trading at HKD 13.07 with a turnover of HKD 130 million. The drop is linked to a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","HK0000320264.USD","BK1583","BK1576","BK4505","BK4585","01548","HK0000306685.HKD","BK1610","BK4139","LEGN","HK0000320223.HKD","BK1141","02800","BK4588"],"gpt_icon":1},{"id":"2605455645","title":"Legend Biotech downgraded to Hold from Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2605455645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605455645?lang=en_us&edition=fundamental","pubTime":"2026-01-22 10:55","pubTimestamp":1769050509,"startTime":"0","endTime":"0","summary":"TD Cowen downgraded Legend Biotech (LEGN) to Hold from Buy with a price target of $21, down from $62. The company’s Q4 miss for Carvykti at $555M v...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-downgraded-to-hold-from-buy-at-td-cowen-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-downgraded-to-hold-from-buy-at-td-cowen-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","COWN","LABU","TD"],"gpt_icon":0},{"id":"2605434401","title":"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605434401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605434401?lang=en_us&edition=fundamental","pubTime":"2026-01-22 08:01","pubTimestamp":1769040070,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Legend Biotech (LEGN – Research Report) and Johnso...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-johnson-johnson-jnj-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-johnson-johnson-jnj-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","LU0345770993.USD","LU1196500208.SGD","LU0787776722.HKD","SG9999002224.SGD","LU1221951046.USD","LU1074936037.SGD","IE0034235303.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LABU","LU1732800096.USD","IE000M9KFDE8.USD","LU1894683348.USD","LU0792757196.USD","IE00B4R5TH58.HKD","LU0795875086.SGD","BK4532","BK4505","LU1496350502.SGD","LU1032466523.USD","LU0070217475.USD","LU1280957306.USD","XLV","JNJ","LU1718418525.SGD","LU0795875169.SGD","SG9999002232.USD","BK4592","BK4007","IE00BVYPNW00.USD","LU1261432733.SGD","LU2471134952.CNY","IE00BN8TJ469.HKD","LU1066051498.USD","LU2468319806.SGD","SG9999001440.SGD","HCSG","IE00BBT3K403.USD","BK4534","LU2089984988.USD","XBI","IE00BJT1NW94.SGD","LU0029874061.USD","IE00BKVL7J92.USD","LU0124676726.USD","LEGN","LU1066053197.SGD","IE00BGHQF631.EUR","LU1221951129.SGD"],"gpt_icon":0},{"id":"2605487541","title":"Legend Biotech Down Over 14%, on Track for Record Low Close -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605487541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605487541?lang=en_us&edition=fundamental","pubTime":"2026-01-22 02:59","pubTimestamp":1769021940,"startTime":"0","endTime":"0","summary":"Legend Biotech Corp. Sponsored ADR  is currently at $20.10, down $3.32 or 14.19%. --On pace for largest percent decrease since Dec. 15, 2021, when it fell 15.25%. --Down 73.73% from its all-time closing high of $76.50 on July 28, 2023. --Down 46.33% from 52 weeks ago , when it closed at $37.44. --Down 54.66% from its 52-week closing high of $44.32 on July 23, 2025. --Traded as low as $19.61; new all-time intraday low . --Down 16.27% at today's intraday low; largest intraday percent decrease since Dec. 15, 2021, when it fell as much as 18.93%","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","BK4585","BK4139","LABU","LEGN"],"gpt_icon":0},{"id":"2605248505","title":"Legend Biotech falls -10.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605248505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605248505?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:06","pubTimestamp":1769007974,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) is down -10.5%, or -$2.46 to $20.96. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-falls-10-5-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-falls-10-5-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4585","LABU","BK4588","BK4139","LEGN"],"gpt_icon":0},{"id":"2605710009","title":"Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605710009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605710009?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:42","pubTimestamp":1769002960,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corvus Pharmaceuticals (CRVS – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-corvus-pharmaceuticals-crvs-and-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-corvus-pharmaceuticals-crvs-and-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4588","XLV","BK4585","LEGN","BK4505","CRVS","LABU","BK4581","LU0029874061.USD","HCSG","BK4139","BK4137","XBI","LU0128526141.USD"],"gpt_icon":0},{"id":"2605102175","title":"Legend Biotech Highlights New CARVYKTI Clinical Data at 2026 Tandem Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102175?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000446,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation announced that it will present six poster presentations featuring new data on CARVYKTI  at the 2026 Tandem Meetings of ASTCT, scheduled for February 4-7, 2026. The presentations will highlight CARVYKTI efficacy, safety, and real-world outcomes across various CARTITUDE trials and analyses. Topics include quality-adjusted survival analysis of neurologic events, effectiveness of bridging therapy, manufacturing outcomes, and long-term progression-free survival benefit in multiple myeloma. The results will be presented at the conference and have not yet been publicly presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL2q15S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","BK4588","IE00BGHQF748.EUR","BK4505","LU2095319765.USD","LEGN","BK4112","BK4585","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","BK4139","SG9999014039.USD"],"gpt_icon":0},{"id":"2605104626","title":"Legend Biotech Reports Preliminary $555 Million CARVYKTI Sales for Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2605104626","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605104626?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:30","pubTimestamp":1768998651,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation announced preliminary business results for the quarter ended December 31, 2025. According to information provided by Janssen, CARVYKTI generated approximately $555 million in net trade sales during the quarter. The sales figure is based on data available to Legend Biotech as of the date of the announcement and has not been independently verified by the company. The determination of revenue or gross profit to be recorded in Legend Biotech's consolidated financial statements is subject to completion by management and review by independent auditors. The company noted that actual results may differ materially from forward-looking statements due to various factors, including regulatory actions, clinical trial outcomes, and market competition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL29JGqC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4588","BK4139","LEGN"],"gpt_icon":0},{"id":"2605148116","title":"Legend Biotech Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605148116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605148116?lang=en_us&edition=fundamental","pubTime":"2026-01-21 01:44","pubTimestamp":1768931040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 12:44 ET (17:44 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","LABU"],"gpt_icon":0},{"id":"2605411083","title":"FDA draft guidance favorable for Legend Biotech, says RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411083","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605411083?lang=en_us&edition=fundamental","pubTime":"2026-01-21 00:25","pubTimestamp":1768926314,"startTime":"0","endTime":"0","summary":"The FDA issued draft guidance supporting the use of minimal residual disease negativity and complete response rate as accelerated approval endpoint...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-draft-guidance-favorable-for-legend-biotech-says-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-draft-guidance-favorable-for-legend-biotech-says-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","BK4585","LU0310800379.SGD","BK4588","LEGN","LU0708994859.HKD","BK4207","LU0029864427.USD","BK4505","LABU","LU1267930573.SGD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0794},{"period":"1month","weight":-0.195},{"period":"3month","weight":-0.4599},{"period":"6month","weight":-0.549},{"period":"1year","weight":-0.5298},{"period":"ytd","weight":-0.195}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1437},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.047546},{"month":2,"riseRate":0.4,"avgChangeRate":0.004169},{"month":3,"riseRate":0.4,"avgChangeRate":-0.028053},{"month":4,"riseRate":0.8,"avgChangeRate":0.075373},{"month":5,"riseRate":0.4,"avgChangeRate":0.007649},{"month":6,"riseRate":1,"avgChangeRate":0.150366},{"month":7,"riseRate":0.666667,"avgChangeRate":0.033873},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.05555},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.023313},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.000245},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.020911},{"month":12,"riseRate":0,"avgChangeRate":-0.105244}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}